Drug Index


Mechanism :

Cyclosporine is a potent immunosuppressive agent which in animals prolongs survival of allogenic transplants involving skin, heart, kidney, pancreas, bone marrow, small intestine and lung. Cyclosporine has been demonstrated to suppress some humoral immunity and to a greater extent, cell-mediated reactions such as allograft rejection, delayed hypersensitivity and graft vs. host disease.

Indication :

  • Psoriasis
  • Juvenile idiopathic arthritis
  • Atopic dermatitis
  • Collagen vascular disorders
  • Uveitis
  • Vasculitis
  • Ulcerative colitis
  • Crohn’s disease
  • Graft versus host disease
  • Organ transplant (off-label)

Contraindications :

Cyclosporine is contraindicated in patients with a hypersensitivity to cyclosporine, abnormal renal function, uncontrolled hypertension, uncontrolled infections and malignancy.

Dosing :

Juvenile idiopathic arthritis, collagen disease, vasculitis, uveitis:
1-2 mg/kg/dose BDS; increased gradually upto 3 mg/kg/dose BDS.
Organ transplant:
5-7 mg/kg/dose BDS starting 12 hours before transplant and continued for 1-2 weeks postoperatively, gradually reducing to maintenance dose of 1-3 mg/kg/dose BDS.
Bone marrow transplant:
6-7.5 mg/kg/dose BDS starting one day prior to transplant.
Psoriasis/atopic dermatitis:
1.25 mg/kg/dose BDS increased, if no response, after 2 weeks for dermatitis and 4 weeks for psoriasis till 2.5 mg/kg/dose BDS.
Severe ulcerative colitis:
3-4 mg/kg/dose BDS.
Crohn’s disease:
2.5-4.5 mg/kg/dose BDS.

Adverse Effect :

Renal dysfunction, tremor, hirsutism, hypertension, and gum hyperplasia. Others: Hepatic impairment, fatigue, gingival hypertrophy, abdominal pain, nausea, vomiting and diarrhea, headache, rash and hyperkalemia.

Interaction :

Drugs that potentiate renal dysfunction: Antibiotics, antineoplastics, antifungals, anti-inflammatory drugs, immunosuppressive.
Drugs that increase cyclosporin concentrations: CCBs, antifungals, glucocorticoids.
Drugs that decrease cyclosporin levels: Nafcillin, rifampicin, anti-convulsants.
Nonsteroidal Anti-inflammatory Drug (NSAID) Interactions: Serum creatinine should be closely monitored when cyclosporine is used with nonsteroidal anti-inflammatory agents in rheumatoid arthritis patients.
Methotrexate Interaction: When methotrexate and cyclosporine were coadministered to rheumatoid arthritis patients, methotrexate concentrations were increased.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in normal renal function; adjust according to levels
HDNot dialysed. Dose as in normal renal function; adjust according to levels
HDF/High fluxUnknown dialysability. Dose as in normal renal function; adjust according to levels
CAV/VVHDNot dialysed. Dose as in normal renal function; adjust according to levels

Hepatic Dose :

Reduction in dose may be required. Monitor serum cyclosporine levels.
03/20/2024 11:41:28 Cyclosporine
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0